How China’s Medicinal Monopoly Leaves the World Vulnerable

How China’s Medicinal Monopoly Leaves the World Vulnerable
Protective N-95 face masks lie on a table at an office in Washington on Feb. 26, 2020. Eva Hambach/AFP/Getty Images
Maya Carlin
Updated:
Commentary

The Chinese regime stunned the world this year with its gross misconduct and concealment of critical facts that led to the emergence and spread of COVID-19. Beijing’s stonewalling efforts directly resulted in the rapid spread of the novel coronavirus, the collapse of regional economies, and the inability of countries to prepare for and respond effectively to the outbreak. Even more concerning, as countries struggled to grapple with the burden of the virus, the regime used its medicinal monopoly as a tool to shut down dissent against its dangerous behavior.

Maya Carlin
Maya Carlin
Author
Maya Carlin is an analyst at the Center for Security Policy, located in Washington, D.C. She is also a M.A. candidate in Counter-Terrorism and Homeland Security at IDC Herzliya’s Lauder School of Government in Israel.
Related Topics